2021
Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells
Tran TT, Rane CK, Zito CR, Weiss SA, Jessel S, Lucca L, Lu BY, Oria VO, Adeniran A, Chiang VL, Omay SB, Hafler DA, Kluger HM, Jilaveanu LB. Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells. Cancers 2021, 13: 1049. PMID: 33801444, PMCID: PMC7958624, DOI: 10.3390/cancers13051049.Peer-Reviewed Original ResearchPDCD4 expressionImproved survivalTumor-Associated Immune CellsTumor microenvironmentNeoplastic progressionBrain metastasis outcomesExtracranial metastatic diseaseMelanoma brain metastasesNatural killer cellsBrain metastasis samplesImmune cell infiltrationImmune cell subsetsMultiple tissue microarraysExpression of PDCD4Brain metastasesMetastatic diseaseClinical outcomesKiller cellsClinicopathological variablesIntracranial metastasesCell subsetsCell infiltrationCell death 4Immune cellsPrimary melanoma
2019
Comparative analysis of CEACAM1 expression in thin melanomas with and without regression
Nichita L, Zurac S, Bastian A, Stinga P, Nedelcu R, Brinzea A, Turcu G, Ion D, Jilaveanu L, Sticlaru L, Popp C, Cioplea M. Comparative analysis of CEACAM1 expression in thin melanomas with and without regression. Oncology Letters 2019, 17: 4149-4154. PMID: 30944609, PMCID: PMC6444332, DOI: 10.3892/ol.2019.10067.Peer-Reviewed Original ResearchCarcinoembryonic antigen-related cell adhesion molecule 1CEACAM1 expressionThin melanomasMelanoma cell invasionTumor cellsHomophilic interactionsAA-1Extracellular domainStructural roleNatural killer cell activityCell invasionCell adhesion molecule-1Key moleculesKiller cell activityNatural killer cellsDeep invasive frontAdhesion molecule-1Full lengthValuable modelCEACAM1 overexpressionDifferent clonesExpressionKiller cellsTumor immunityClones